A case report demonstrating that follicle maturing drugs may create an adverse uterine environment even when not used for controlled ovarian hyperstimulation

Clinical and Experimental Obstetrics and Gynecology

Volumn 28, Issue 4, 2001, Pages 217-218

  Check, Jerome H ^a   Check, M L ^a  

^a NONE   (United States)

Author keywords

Adverse uterine environment; Follicle maturing drugs; Progesterone supplementation; Refractory infertility

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; PROGESTERONE;

ADULT; ARTICLE; CASE REPORT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; LUTEAL INSUFFICIENCY; MENSTRUAL CYCLE; NIDATION; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; UTERUS DISEASE;

ADULT; CLOMIPHENE; EMBRYO TRANSFER; ESTROGEN ANTAGONISTS; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; LUTEAL PHASE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE; UTERUS;

EID: 0035711908     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Ovulation-inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects
2. Embryo implantation after human in vitro fertilization importance of endometrial receptivity
3. Evaluation of the mechanism for higher pregnancy rates in donor oocyte recipients by comparison of fresh with frozen embryo transfer pregnancy rates in a shared oocyte programme
4. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients
5. Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer
6. Ovarian hyperstimulation can reduce uterine receptivity. A case report
7. An evaluation of etiologic factors and therapy in 555 private patients with primary infertility
8. The diagnosis and therapy of luteal phase deficiency
9. Outcome of progesterone treatment of luteal phase inadequacy